What’s the one CBD issue that sets tongues, and tails, wagging?

CBD: Why can't we give some to our pets?

Many of the CBD products we use as humans are tested on animals. So why can’t we give it to our pets? In the UK, the Veterinary Medicines Directorate (VMD) considers CBD products intended for animal use to be veterinary medicines, making it illegal to administer cannabinoids to our pets without a prescription. To date, […]

The Hodges Review gauges public support for the UK’s ‘accidental’ cannabis sector

public support for the UK's cannabis sector

The main objective of the Hodges Review was to examine the current cannabis sector landscape and outline how best to support the safe and responsible growth – economic and social – of a sizeable and dynamic legal sector that is already established in the UK.  Despite the growth potential and dedication within the industry, the report […]

EFSA reveals several areas of concern in novel food applications

novel food

The European Food Safety Authority (EFSA) has found several key areas of concern in novel food submissions it has received for CBD.   Among the areas of primary concern are missing information on applications and data gaps, which would support the evaluation of safety profiles, according to information shared during an EFSA-led webinar on 29 June.  […]

CBD in food: 12,000 products now pending authorisation as FSA releases final list

CBD in food

The Food Standards Agency has updated the public list of CBD products, adding an additional 6,000 products. This is the complete list of ingestible CBD products currently allowed to remain on the market, which have been linked to a credible novel foods application.    These are the only ingestible CBD products which can be sold […]

EFSA suspends novel food applications due to ‘data gaps and uncertainties’ 

lab tests

The European Food Safety Authority (EFSA) has ‘stopped the clock’ on 19 novel food applications for CBD, pending new data. The EU authority says its scientists cannot currently establish the safety of CBD as a novel food due to data gaps and uncertainties about potential hazards related to CBD intake. The news follows the submission […]

Experts in botanical ingredients turn their attention to cannabinoids 

It’s not often you come across a company in the CBD world that has four decades of history. Susanne Caspar, Chief Executive of Linnea talks about succeeding in the botanical ingredients business and opening the doors to cannabinoids.  Located in Switzerland, Linnea has been delivering botanical ingredients to the pharmaceutical, food and cosmetic industries across […]

Celebrating 3 years of Naturecan

Naturecan co-founders Paul and Andrew pictured

Naturecan, the UK CBD brand born out of Stockport, is celebrating three years in business. We caught up with some of the team to look back on the highlights of the company’s journey so far.  It all started with a lightbulb moment in 2018, when Naturecan co-founder Paul Finnegan had an idea to create CBD […]

Back on track: Swiss ingredients manufacturer Linnea reinstated on FSA’s CBD list 

a green correct mark

Linnea, the expert manufacturer of botanical extracts for the pharmaceutical industry, has had its novel foods application reinstated by the Food Standards Agency, following its removal from the list earlier this year.  Cannabinoid Insight understands the company was originally told its application had been validated, only for the FSA to later rule Linnea out due […]